nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AMPK, the metabolic syndrome and cancer
|
Luo, Zhijun |
|
2005 |
26 |
2 |
p. 69-76 8 p. |
artikel |
2 |
A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?
|
Francis, Paul T. |
|
2005 |
26 |
2 |
p. 104-111 8 p. |
artikel |
3 |
Contents page + Editorial Board
|
|
|
2005 |
26 |
2 |
p. i- 1 p. |
artikel |
4 |
Hartnup disorder: unraveling the mystery
|
Kraut, Jeffrey A. |
|
2005 |
26 |
2 |
p. 53-55 3 p. |
artikel |
5 |
Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity
|
Villarroya, Francesc |
|
2005 |
26 |
2 |
p. 88-93 6 p. |
artikel |
6 |
Medication-overuse headache: similarities with drug addiction
|
Calabresi, Paolo |
|
2005 |
26 |
2 |
p. 62-68 7 p. |
artikel |
7 |
Neuropeptide G-protein-coupled receptors, their cognate ligands and behavior in Caenorhabditis elegans
|
Geary, Timothy G. |
|
2005 |
26 |
2 |
p. 56-58 3 p. |
artikel |
8 |
Neurotoxicity of MDMA (ecstasy): beyond metabolism
|
Sprague, Jon E. |
|
2005 |
26 |
2 |
p. 59-60 2 p. |
artikel |
9 |
Overcoming limitations of natural anticancer drugs by combining with artificial agents
|
Blagosklonny, Mikhail V. |
|
2005 |
26 |
2 |
p. 77-81 5 p. |
artikel |
10 |
Response to Sprague and Nichols: Contribution of metabolic activation to MDMA neurotoxicity
|
de la Torre, Rafael |
|
2005 |
26 |
2 |
p. 60-61 2 p. |
artikel |
11 |
The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension
|
Porcu, Marco |
|
2005 |
26 |
2 |
p. 94-103 10 p. |
artikel |
12 |
Why does the rapid delivery of drugs to the brain promote addiction?
|
Samaha, Anne-Noël |
|
2005 |
26 |
2 |
p. 82-87 6 p. |
artikel |